
- Pharmaceutical Technology's In the Lab eNewsletter, September 2022
- Volume 17
- Issue 9
CYTENA Unveils Fully Automated Single-Cell Dispenser for Microorganisms
CYTENA’s B.SIGHT cell dispenser is designed to streamline single-cell isolation in microbiology research.
CYTENA, a BICO group company and supplier of high-precision laboratory equipment for handling biological cells, recently unveiled the next generation of B.SIGHT, a fully automated single-cell dispenser. The B.SIGHT instrument is designed to streamline single-cell isolation in microbiology research, with emphasis placed on handling bacteria, yeast, and other microorganisms.
“The new B.SIGHT brings isolation of bacteria and yeast to the next level,” said Julian Riba, CEO, CYTENA, in an Aug. 8, 2022 company press release.. “This second generation single-cell dispenser is really the outcome of a great collaboration between our team and our customers.”
“The new instrument provides more automation, faster processing speeds, higher resolution, and precise dispensing,” said Hussein Hamzeh, the product manager in charge of B.SIGHT, in the release. “Researchers using the B.SIGHT not only will be able to accelerate microorganism isolation workflows but also significantly reduce plastic waste.”
Source:
Articles in this issue
about 3 years ago
Accelerating Time-to-Insight Throughout the BioPharma Lifecycleabout 3 years ago
Integrated Approaches to the Data Lifecycleabout 3 years ago
Bio-Rad Launches Anti-Evolocumab Antibodiesabout 3 years ago
Roche Launches Digital PCR Systemabout 3 years ago
Canvax Releases New Inorganic Pyrophosphateover 3 years ago
Merck Enters Alzheimer’s Collaboration with Cerevanceover 3 years ago
La Jolla Institute for Immunology Acquires Carterra LSA PlatformNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





